Alpha 2.0
Login Register
» Articles » PMID: 11222346

Incidence of Blindness Due to Diabetic Eye Disease in Fife 1990-9

Overview
Journal Br J Ophthalmol
Specialty Ophthalmology
Date 2001 Feb 27
PMID 11222346
Citations 8
Authors
T G Cormack
B Grant
M J MacDonald
J Steel
I W Campbell
Affiliations
Soon will be listed here.
Abstract

Aims: In the light of goals for reducing blindness due to diabetes, published in the St Vincent Declaration, 1989, the aim of this study was to find the incidence and prevalence of blindness in the diabetic population of Fife.

Methods: All blind registrations for the period 1990-9 were studied. Those with diabetes as the first or main diagnosis were included as new diabetic blind. The prevalence of diabetes was studied in a large sample population and extrapolated to the estimated population of Fife.

Results: The incidence of blindness due to diabetes was 64 (SD 24, 95% CI 49-79) per 100 000 diabetic population/year. The point prevalence of blindness due to diabetes on 31 December 1999 was 210 per 100 000 diabetic population.

Conclusion: The incidence of blindness due to diabetes, in a diabetic population, is now known. Without this benchmark it is impossible to assess the implementation of the St Vincent Declaration.

Citing Articles

The contribution of the English NHS Diabetic Eye Screening Programme to reductions in diabetes-related blindness, comparisons within Europe, and future challenges.

Scanlon P Acta Diabetol. 2021; 58(4):521-530.

PMID: 33830332 PMC: 8053650. DOI: 10.1007/s00592-021-01687-w.

The effect of geodemographic factors on the attendance rates at a regional diabetic retinopathy treatment centre.

Greenan E, Salim M, Coakley D, James M Ir J Med Sci. 2019; 188(4):1207-1212.

PMID: 31001789 DOI: 10.1007/s11845-019-02009-4.

Retrospective analysis of newly recorded certifications of visual impairment due to diabetic retinopathy in Wales during 2007-2015.

Thomas R, Luzio S, North R, Banerjee S, Zekite A, Bunce C BMJ Open. 2017; 7(7):e015024.

PMID: 28720613 PMC: 5541630. DOI: 10.1136/bmjopen-2016-015024.

Prevalence and causes of visual impairment in diabetic patients in Tunisia, North Africa.

Kahloun R, Jelliti B, Zaouali S, Attia S, Ben Yahia S, Resnikoff S Eye (Lond). 2014; 28(8):986-91.

PMID: 24924439 PMC: 4135255. DOI: 10.1038/eye.2014.131.

Ethnic variation in the prevalence of visual impairment in people attending diabetic retinopathy screening in the United Kingdom (DRIVE UK).

Sivaprasad S, Gupta B, Gulliford M, Dodhia H, Mann S, Nagi D PLoS One. 2012; 7(6):e39608.

PMID: 22761840 PMC: 3384630. DOI: 10.1371/journal.pone.0039608.

References
1.
Grey R, Burns-Cox C, Hughes A . Blind and partial sight registration in Avon. Br J Ophthalmol. 1989; 73(2):88-94. PMC: 1041661. DOI: 10.1136/bjo.73.2.88. View
2.
Agardh E, Agardh C . The five-year incidence of blindness after introducing a screening programme for early detection of treatable diabetic retinopathy. Diabet Med. 1993; 10(6):555-9. DOI: 10.1111/j.1464-5491.1993.tb00120.x. View
3.
Moss S, Klein R, Klein B . Ten-year incidence of visual loss in a diabetic population. Ophthalmology. 1994; 101(6):1061-70. DOI: 10.1016/s0161-6420(94)31217-6. View
4.
Trautner C, Icks A, Haastert B, Plum F, Berger M . Incidence of blindness in relation to diabetes. A population-based study. Diabetes Care. 1997; 20(7):1147-53. DOI: 10.2337/diacare.20.7.1147. View
5.
Nabarro J . Diabetes in the United Kingdom: some facts and figures. Diabet Med. 1988; 5(9):816-22. DOI: 10.1111/j.1464-5491.1988.tb01117.x. View